| Quarterly Financials | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 100 | 184 | 138 | 148 | 146 | 162 | 235 | 241 | 226 | 239 | 198 | 173 | 219 | 253 | 217 | 247 | 214 | 223 | 153 | 139 | 137 | 154 | 168 | 138 | 176 | 201 | 222 | 179 | 196 | 175 | 211 | 188 | 165 | 225 | 206 | 204 | 188 | 223 | 226 | 210 | 243 | 253 | 237 | 268 |
| Expenses | 60 | 132 | 104 | 95 | 101 | 126 | 187 | 182 | 161 | 179 | 148 | 164 | 165 | 187 | 177 | 212 | 163 | 185 | 115 | 117 | 110 | 120 | 126 | 115 | 134 | 167 | 256 | 147 | 150 | 148 | 158 | 179 | 135 | 158 | 157 | 199 | 149 | 176 | 181 | 177 | 166 | 201 | 186 | 213 |
| EBITDA | 40 | 51 | 34 | 52 | 46 | 36 | 48 | 60 | 65 | 61 | 50 | 9 | 55 | 66 | 40 | 35 | 51 | 38 | 39 | 21 | 27 | 35 | 42 | 23 | 42 | 35 | -33 | 32 | 46 | 27 | 53 | 9 | 29 | 67 | 49 | 5 | 39 | 47 | 45 | 33 | 77 | 52 | 51 | 56 |
| Operating Profit % | 36 % | 25 % | 21 % | 34 % | 27 % | 21 % | 18 % | 27 % | 28 % | 20 % | 25 % | 2 % | 20 % | 18 % | 20 % | 13 % | 23 % | 12 % | 22 % | 2 % | 15 % | 21 % | 23 % | 13 % | 21 % | 15 % | -18 % | 12 % | 21 % | 14 % | 23 % | 3 % | 15 % | 26 % | 22 % | -0 % | 19 % | 19 % | 14 % | 11 % | 20 % | 18 % | 15 % | 17 % |
| Depreciation | 3 | 6 | 3 | 2 | 4 | 4 | 11 | 1 | 5 | 5 | 7 | 5 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 |
| Interest | 5 | 5 | 2 | 7 | 4 | 4 | 4 | 8 | 7 | 6 | 5 | 5 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 2 | 0 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 5 | 2 | 2 | 2 | 2 | 2 | 4 | 1 | 2 | 6 | 3 | 2 | 2 |
| Profit Before Tax | 33 | 41 | 31 | 43 | 41 | 36 | 38 | 60 | 56 | 52 | 39 | -1 | 51 | 63 | 37 | 32 | 47 | 34 | 34 | 13 | 20 | 30 | 37 | 17 | 37 | 30 | -39 | 27 | 39 | 20 | 47 | -1 | 22 | 59 | 40 | -4 | 30 | 36 | 36 | 23 | 63 | 41 | 41 | 45 |
| Tax | 13 | 13 | 7 | 15 | 13 | 15 | 17 | 18 | 19 | 12 | 13 | 12 | 12 | 21 | 9 | 13 | 14 | 3 | 9 | 8 | 4 | 8 | 10 | 8 | 11 | 8 | 10 | 3 | 12 | 4 | 18 | -4 | 7 | 16 | 11 | 1 | 8 | 10 | 11 | 7 | 19 | 12 | 16 | 8 |
| Net Profit | 20 | 28 | 24 | 29 | 28 | 21 | 22 | 43 | 37 | 40 | 26 | -14 | 39 | 42 | 27 | 19 | 33 | 31 | 26 | 6 | 17 | 22 | 28 | 8 | 26 | 22 | -49 | 24 | 28 | 16 | 30 | 4 | 14 | 43 | 29 | -5 | 22 | 26 | 26 | 17 | 44 | 29 | 25 | 37 |
| EPS in ₹ | 1.89 | 2.23 | 2.15 | 1.71 | 2.67 | 2.46 | 2.02 | 3.21 | 2.05 | 4.93 | 1.74 | -1.39 | 3.72 | 4.02 | 2.50 | 1.76 | 3.28 | 3.00 | 2.30 | 0.85 | 1.57 | 1.99 | 2.48 | 0.61 | 2.35 | 2.05 | -4.83 | 1.90 | 2.48 | 1.33 | 2.68 | 0.34 | 1.41 | 4.06 | 2.64 | -0.88 | 1.97 | 2.31 | 2.27 | 1.47 | 4.08 | 2.58 | 2.20 | 3.22 |
Bliss GVS Pharma
Bliss GVS Pharma
497.00
+7.25
(1.48%)
Market Cap
5,257.71 Cr
PE Ratio
38.56
Volume
2,98,823.00
Day High - Low
511.95 - 493.10
52W High-Low
553.00 - 118.00
Key Fundamentals
Market Cap
5,257.71 Cr
EPS
12.23
PE Ratio
38.56
PB Ratio
4.35
Book Value
112.28
EBITDA
237.60
Dividend Yield
0.20 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
10.94
Debt to Equity
0.05
Actual
Company News
View All News
Bliss GVS Pharma Limited has accepted the resignation of Sachin Saboo, General Manager – Regulatory & Clinical, effective July 24, 2026. He cited professional aspirations as the reason for his departure.
Anupam Rasayan adds Mates Visa as PAC
Jul 19, 2026
Jul 19, 2026Anupam Rasayan India Ltd designated Mates Visa Consultancy Pvt Ltd as a person acting in concert for its open offer to acquire 26% of Bliss GVS Pharma Ltd.
Bliss GVS Pharma declares final dividendJul 15, 2026
Jul 15, 2026Bliss GVS Pharma declared a final dividend of Re. 1.00 per share for FY26 at its 41st AGM. Shareholders approved financial statements and director re-appointment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,940.00 | #1 4,65,470.98 | 38.81 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 50.92 | |
8,388.00 | 2,22,675.04 | 75.98 | 11,067.00 | 13.95 | 2,568 | 65.50 | 78.01 | |
5,000.00 | 1,90,183.93 | 88.74 | 13,886.20 | 20.34 | 2,138 | 3.28 | 56.32 | |
1,458.80 | 1,17,848.47 | 34.91 | 29,044.60 | 2.24 | 3,870 | -39.18 | 56.44 | |
1,121.10 | 1,12,808.89 | 21.78 | 27,657.90 | 17.64 | 5,026 | 7.82 | 50.68 | |
2,388.00 | 1,09,187.13 | #1 20.29 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 46.22 | |
2,435.60 | 1,00,589.30 | 49.16 | 14,636.40 | 14.85 | 1,938 | 29.13 | 42.08 | |
1,835.00 | 99,063.68 | 90.96 | 6,867.80 | 22.01 | 890 | #1 123.93 | 79.16 | |
1,176.00 | 98,157.08 | 30.43 | 35,058.60 | 3.90 | 4,158 | -69.10 | 39.52 | |
1,613.40 | 92,831.47 | 26.26 | 33,384.70 | 3.21 | 3,376 | 1.99 | 61.47 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
18.25 %
Net Income Growth
49.17 %
Cash Flow Change
30.98 %
ROE
32.29 %
ROCE
35.36 %
EBITDA Margin (Avg.)
23.13 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 662 | 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| Fixed Assets | 234 | 225 | 305 | 143 | 146 | 242 | 234 | 282 | 379 | 370 | 406 | 459 |
| Current Assets | 417 | 471 | 566 | 690 | 694 | 770 | 765 | 777 | 697 | 811 | 824 | 946 |
| Capital Work in Progress | 0 | 9 | 4 | 1 | 47 | 0 | 2 | 22 | 3 | 8 | 21 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 4 | 4 | 5 |
| Other Assets | 428 | 527 | 714 | 717 | 712 | 786 | 840 | 803 | 768 | 830 | 871 | 1,022 |
| Total Equity & Liabilities | 662 | 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 |
| Current Liabilities | 243 | 267 | 437 | 299 | 207 | 231 | 204 | 233 | 193 | 157 | 172 | 236 |
| Non Current Liabilities | 68 | 50 | 33 | 13 | 38 | 46 | 45 | 29 | 46 | 51 | 37 | 25 |
| Total Equity | 352 | 446 | 553 | 548 | 660 | 750 | 828 | 847 | 917 | 1,003 | 1,092 | 1,232 |
| Reserve & Surplus | 327 | 402 | 476 | 526 | 636 | 725 | 798 | 808 | 874 | 957 | 1,040 | 1,182 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -34 | 23 | 30 | -11 | -22 | 0 | -2 | 9 | 3 | -1 | 0 | 11 |
| Investing Activities | -30 | -50 | -249 | 48 | -79 | -40 | -45 | -103 | -6 | -83 | -76 | -38 |
| Operating Activities | 38 | 113 | 290 | 18 | 40 | 47 | 64 | 136 | 34 | 103 | 106 | 139 |
| Financing Activities | -42 | -40 | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 | -89 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 33.31 % | 33.24 % | 33.19 % | 33.14 % | 33.14 % | 34.51 % | 34.55 % | 34.46 % | 35.04 % | 35.12 % | 35.06 % | 34.97 % | 34.97 % | 34.90 % | 34.82 % | 35.10 % | 35.29 % | 35.44 % | 35.39 % | 35.36 % | 35.36 % | 35.01 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 16.31 % | 0.00 % | 14.73 % | 13.25 % | 12.13 % | 13.51 % | 13.18 % | 12.65 % | 13.27 % | 14.54 % | 10.45 % | 8.07 % |
| DIIs | 6.72 % | 6.72 % | 6.67 % | 6.66 % | 6.66 % | 6.65 % | 6.64 % | 6.63 % | 6.63 % | 6.62 % | 6.61 % | 6.59 % | 6.59 % | 6.58 % | 6.57 % | 6.55 % | 6.55 % | 6.54 % | 5.98 % | 5.78 % | 5.04 % | 9.47 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.45 % | 26.90 % | 27.59 % | 28.26 % | 30.37 % | 30.15 % | 30.57 % | 30.74 % | 30.00 % | 30.10 % | 29.17 % | 30.78 % | 31.71 % | 32.84 % | 34.57 % | 32.93 % | 32.63 % | 32.79 % | 32.85 % | 31.48 % | 32.60 % | 29.77 % |
| Others | 36.52 % | 33.14 % | 32.55 % | 31.95 % | 29.84 % | 28.69 % | 28.24 % | 28.18 % | 28.33 % | 28.15 % | 12.84 % | 27.66 % | 12.00 % | 12.43 % | 11.92 % | 11.91 % | 12.34 % | 12.58 % | 12.51 % | 12.84 % | 16.55 % | 17.68 % |
| No of Share Holders | 28,543 | 39,999 | 42,742 | 41,080 | 45,866 | 46,327 | 45,753 | 44,983 | 43,041 | 42,182 | 43,234 | 40,758 | 45,157 | 44,737 | 52,937 | 49,558 | 49,517 | 46,707 | 44,461 | 43,380 | 44,874 | 46,767 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.6 | 1 | 1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Dividend Yield (%) | 0.31 | 0.56 | 0.99 | 0.51 | 0.65 | 0.71 | 0.44 | 0.42 | 0.23 | 0.1 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Sept 2021 |  Dividend | ₹ 0.50 /share | 13 Sept 2021 | 122.40 | 110.50 |
| 21 Jun 2022 | Dividend | ₹ 0.50 /share | 20 Jun 2022 | 80.40 | 72.15 |
| 28 Jun 2022 |  Annual General Meeting | NA | 28 Jun 2022 | 80.40 | 75.10 |
| 13 Jul 2023 | Dividend | ₹ 0.50 /share | 12 Jul 2023 | 82.15 | 82.95 |
| 19 Jul 2023 | Annual General Meeting | NA | 19 Jul 2023 | 83.76 | 101.70 |
| 19 Jul 2024 | Dividend | ₹ 0.50 /share | 18 Jul 2024 | 123.60 | 111.29 |
| 25 Jul 2024 | Annual General Meeting | NA | 25 Jul 2024 | 123.60 | 121.20 |
| 24 Oct 2024 |  Quarterly Result Announcement | NA | 24 Oct 2024 | 127.93 | 126.75 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 173.80 | 150.79 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 117.80 | 111.84 |
| 24 Jul 2025 | Dividend | ₹ 0.50 /share | 24 Jul 2025 | 111.84 | 156.90 |
| 29 Jul 2025 | Quarterly Result Announcement | NA | 29 Jul 2025 | 161.90 | 155.11 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 111.84 | 183.17 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 152.04 | 153.85 |
| 10 Feb 2026 | Quarterly Result Announcement | NA | 10 Feb 2026 | 172.77 | 203.75 |
| 18 Feb 2026 | Dividend | ₹ 0.50 /share | 18 Feb 2026 | 203.75 | 231.45 |
| 12 May 2026 | Quarterly Result Announcement | NA | 12 May 2026 | 274.40 | 272.15 |
| 08 Jul 2026 | Dividend | ₹ 1.00 /share | 08 Jul 2026 | 272.15 | 511.55 |
| 15 Jul 2026 | Annual General Meeting | NA | 15 Jul 2026 | 272.15 | 521.10 |
Announcements
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday August 12 202630 mins ago
30 mins agoPre-Offer Advertisement & Corrigendum to Detailed Public Statement9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-CessationJul 24, 2026
Jul 24, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2026
Jul 23, 2026Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2018-2019 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) AuthorityJul 23, 2026
Jul 23, 2026Intimation Of Recommendations By The Committee Of Independent Directors (IDC) Pursuant To Regulation 26(7) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Jul 22, 2026
Jul 22, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2026
Jul 22, 2026Letter Of Offer Dated July 18 2026 Received From SBI Capital Markets LimitedJul 21, 2026
Jul 21, 2026Addendum To Public Announcement And Detailed Public StatementJul 19, 2026
Jul 19, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 15, 2026
Jul 15, 2026Proceedings Of 41St Annual General Meeting Of Bliss GVS Pharma LimitedJul 15, 2026
Jul 15, 2026Contact Details Of Kmps For Reporting Of Material Events To Stock ExchangesJul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 07, 2026
Jul 07, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 03, 2026
Jul 03, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Friday July 03 2026Jul 03, 2026
Jul 03, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 03, 2026
Jul 03, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2026
Jun 24, 2026 Intimation Of Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jun 23, 2026
Jun 23, 2026 Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jun 23, 2026
Jun 23, 2026Notice Of The 41St Annual General Meeting (41St AGM) Of Bliss GVS Pharma Limited Jun 23, 2026
Jun 23, 2026Reg. 34 (1) Annual Report.Jun 23, 2026
Jun 23, 2026Communication To Shareholders - Intimation Of Tax Deduction On DividendJun 19, 2026
Jun 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2026
Jun 19, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 11, 2026
Jun 11, 2026Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Jun 09, 2026
Jun 09, 2026Draft Letter of OfferJun 09, 2026
Jun 09, 2026Intimation Of WHO-GMP Compliance Of Manufacturing FacilityJun 02, 2026
Jun 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 02, 2026
Jun 02, 2026Detailed Public StatementJun 01, 2026
Jun 01, 2026Detailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The CompanyJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Public AnnouncementMay 25, 2026
May 25, 2026Disclosure under Regulation 30A of LODRMay 23, 2026
May 23, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 23 2026May 23, 2026
May 23, 2026Public Announcement In Relation To Open Offer To Public Shareholders (As Defined Under Public Announcement) Of The Company Under SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011May 23, 2026
May 23, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2026
May 12, 2026Corporate Action-Board approves DividendMay 12, 2026
May 12, 2026Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
May 12, 2026
May 12, 2026Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31 2026May 12, 2026
May 12, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday May 12 2026May 12, 2026
May 12, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 12, 2026
May 12, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 12, 2026
May 12, 2026Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend If Any For The Year Ended March 31 2026.May 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Apr 10, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 09, 2026
Apr 09, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.23% | 0 | 0.00% | 0.04% | |
 Union Active Momentum Fund Direct-Growth | 2.89% | 0 | 0.00% | -0.22% |
Technical Indicators
RSI(14)
Neutral 56.86
ATR(14)
Less Volatile 22.23
STOCH(9,6)
Neutral 41.85
STOCH RSI(14)
Neutral 54.27
MACD(12,26)
Bearish -2.94
ADX(14)
Weak Trend 23.14
UO(9)
Bearish 46.14
ROC(12)
Uptrend And Accelerating 1.29
WillR(14)
Neutral -40.06
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
